Data / Form D filings / Solaxa Inc.
Solaxa Inc.: Form D filings
Solaxa Inc., a pharmaceuticals company in Bethesda, MD, filed 4 Form D notices with the SEC in 2024. The latest, on September 13, 2024, reports $305,000 sold of a $6 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7272 WISCONSIN AVE, FLOOR 9, Bethesda, MD, 20814
- Phone
- (240) 515-5765
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1975400
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | New notice | $6,000,000 | $305,000 | $5,695,000 | 4 | Aug 29, 2024 | sec.gov |
| May 28, 2024 | New notice | $500,000 | $500,000 | 1 | Nov 29, 2023 | sec.gov | |
| May 28, 2024 | New notice | $729,000 | $729,000 | 13 | Feb 11, 2021 | sec.gov | |
| May 3, 2024 | New notice | $2,094,000 | $365,000 | $1,729,000 | 8 | Apr 24, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Luis Gutierrez | Director | |
| Lauren Sabella | Director | |
| Christian Walker | Executive Officer, Director |
Other pharmaceuticals companies in Maryland that filed recently
- Cerium Pharmaceuticals, Inc. $750,000 · Aug 6, 2026
Every Form D from the week of Sep 9, 2024 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Solaxa Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.